Immuron (IMRN) Gross Margin Growth (1y) (2017 - 2024)

Immuron (IMRN) Gross Margin Growth (1y) (2017 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 372.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -5.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -165.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 236.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Immuron 270.20 Mn 258.54 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -2,183,321.87 Bn
Dec 31, 2023 -623.00
Dec 31, 2022 -6.99 Bn
Dec 31, 2021 3.14 Bn
Dec 31, 2020 3.85 Bn
Dec 31, 2019 -7,587.00
Dec 31, 2018 -241.00
Dec 31, 2017 1,052.00